Literature DB >> 21672660

The molecular biology of colorectal carcinoma and its implications: a review.

Sanjay Harrison1, Harrison Benziger.   

Abstract

Colorectal carcinoma is one of the most common cancers encountered in the western world and increasingly in the developing world as well. This conditions results in considerable morbidity and mortality. As a result of the impact colorectal carcinoma has on society, a considerable amount of research has gone into elucidating the molecular mechanisms of this disease. This has led to a proliferation in the understanding of the molecular aetiology of the disease. Such research has revealed the underlying mechanisms to be complex and diverse, with no single molecular cause for the development of colorectal cancer. In this review, we look at the basic underlying molecular mechanisms of colorectal cancer and also briefly explore its implications with regards to clinical applications. We look at how this information relates to the prognosis and also its potential use in screening. A medline and pubmed search was conducted using the keywords colorectal carcinoma, molecular biology of colorectal carcinoma, mutations, and the relevant articles were used for this review. Bibliographies of these articles were also searched for relevant articles. There is considerable information available on the pathogenesis of colorectal carcinoma and such knowledge is beginning to impact on clinical practice.
Copyright © 2011 Royal College of Surgeons of Edinburgh (Scottish charity number SC005317) and Royal College of Surgeons in Ireland. Published by Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21672660     DOI: 10.1016/j.surge.2011.01.011

Source DB:  PubMed          Journal:  Surgeon        ISSN: 1479-666X            Impact factor:   2.392


  24 in total

1.  Gene promoter methylation in colorectal cancer and healthy adjacent mucosa specimens: correlation with physiological and pathological characteristics, and with biomarkers of one-carbon metabolism.

Authors:  Fabio Coppedè; Francesca Migheli; Angela Lopomo; Alessandra Failli; Annalisa Legitimo; Rita Consolini; Gabriella Fontanini; Elisa Sensi; Adele Servadio; Massimo Seccia; Giuseppe Zocco; Massimo Chiarugi; Roberto Spisni; Lucia Migliore
Journal:  Epigenetics       Date:  2014-01-31       Impact factor: 4.528

Review 2.  Choosing the optimal method in programmatic colorectal cancer screening: current evidence and controversies.

Authors:  Antoni Castells
Journal:  Therap Adv Gastroenterol       Date:  2015-07       Impact factor: 4.409

3.  Function of the macrophage-capping protein in colorectal carcinoma.

Authors:  Wei Wu; Jingdi Chen; Qianshan Ding; Sheng Yang; Jianping Wang; Honggang Yu; Jun Lin
Journal:  Oncol Lett       Date:  2017-09-06       Impact factor: 2.967

Review 4.  Genetic and epigenetic biomarkers for diagnosis, prognosis and treatment of colorectal cancer.

Authors:  Fabio Coppedè; Angela Lopomo; Roberto Spisni; Lucia Migliore
Journal:  World J Gastroenterol       Date:  2014-01-28       Impact factor: 5.742

Review 5.  Segmental distribution of some common molecular markers for colorectal cancer (CRC): influencing factors and potential implications.

Authors:  Petros Christakis Papagiorgis
Journal:  Tumour Biol       Date:  2016-02-03

6.  The anticancer effect of saffron in two p53 isogenic colorectal cancer cell lines.

Authors:  Khuloud Bajbouj; Jan Schulze-Luehrmann; Stefanie Diermeier; Amr Amin; Regine Schneider-Stock
Journal:  BMC Complement Altern Med       Date:  2012-05-28       Impact factor: 3.659

7.  NDST4 is a novel candidate tumor suppressor gene at chromosome 4q26 and its genetic loss predicts adverse prognosis in colorectal cancer.

Authors:  Sheng-Tai Tzeng; Ming-Hong Tsai; Chi-Long Chen; Jing-Xing Lee; Tzu-Ming Jao; Sung-Liang Yu; Sou-Jhy Yen; Ya-Chien Yang
Journal:  PLoS One       Date:  2013-06-25       Impact factor: 3.240

8.  Hepatic arterial infusion but not systemic application of cetuximab in combination with oxaliplatin significantly reduces growth of CC531 colorectal rat liver metastases.

Authors:  Jens Sperling; Thilo Schäfer; Anna Benz-Weißer; Christian Ziemann; Claudia Scheuer; Otto Kollmar; Martin K Schilling; Michael D Menger
Journal:  Int J Colorectal Dis       Date:  2012-12-15       Impact factor: 2.571

9.  Liver-directed chemotherapy of cetuximab and bevacizumab in combination with oxaliplatin is more effective to inhibit tumor growth of CC531 colorectal rat liver metastases than systemic chemotherapy.

Authors:  Jens Sperling; David Brandhorst; Thilo Schäfer; Christian Ziemann; Anna Benz-Weißer; Claudia Scheuer; Otto Kollmar; Martin K Schilling; Michael D Menger
Journal:  Clin Exp Metastasis       Date:  2012-11-27       Impact factor: 5.150

10.  Establishment, characterization and chemosensitivity of three mismatch repair deficient cell lines from sporadic and inherited colorectal carcinomas.

Authors:  Claudia Maletzki; Saskia Stier; Ulrike Gruenert; Michael Gock; Christiane Ostwald; Friedrich Prall; Michael Linnebacher
Journal:  PLoS One       Date:  2012-12-31       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.